422 related articles for article (PubMed ID: 24527948)
1. Update and insights into treatment options for chronic spontaneous urticaria.
Marrouche N; Grattan C
Expert Rev Clin Immunol; 2014 Mar; 10(3):397-403. PubMed ID: 24527948
[TBL] [Abstract][Full Text] [Related]
2. The maddening itch: an approach to chronic urticaria.
Viegas LP; Ferreira MB; Kaplan AP
J Investig Allergol Clin Immunol; 2014; 24(1):1-5. PubMed ID: 24765875
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of chronic spontaneous urticaria.
Makris M; Maurer M; Zuberbier T
Expert Opin Pharmacother; 2013 Dec; 14(18):2511-9. PubMed ID: 24195758
[TBL] [Abstract][Full Text] [Related]
4. Omalizumab is efficacious for management of recalcitrant, antihistamine-resistant chronic urticaria.
Lang DM
Drugs Today (Barc); 2015 Jun; 51(6):367-74. PubMed ID: 26261850
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey.
Büyüköztürk S; Gelincik A; Demirtürk M; Kocaturk E; Colakoğlu B; Dal M
J Dermatol; 2012 May; 39(5):439-42. PubMed ID: 22221177
[TBL] [Abstract][Full Text] [Related]
6. Omalizumab for the treatment of chronic urticaria.
Zuberbier T; Maurer M
Expert Rev Clin Immunol; 2015 Feb; 11(2):171-80. PubMed ID: 25566680
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.
Vestergaard C; Toubi E; Maurer M; Triggiani M; Ballmer-Weber B; Marsland A; Ferrer M; Knulst A; Giménez-Arnau A
Eur J Dermatol; 2017 Feb; 27(1):10-19. PubMed ID: 27882879
[TBL] [Abstract][Full Text] [Related]
8. Childhood urticaria.
Marrouche N; Grattan C
Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):485-90. PubMed ID: 22825024
[TBL] [Abstract][Full Text] [Related]
9. Urticaria and Angioedema: an Update on Classification and Pathogenesis.
Radonjic-Hoesli S; Hofmeier KS; Micaletto S; Schmid-Grendelmeier P; Bircher A; Simon D
Clin Rev Allergy Immunol; 2018 Feb; 54(1):88-101. PubMed ID: 28748365
[TBL] [Abstract][Full Text] [Related]
10. Chronic urticaria: omalizumab and review of therapeutic options.
Bergstrom KG
J Drugs Dermatol; 2013 Jun; 12(6):715-6. PubMed ID: 23839196
[TBL] [Abstract][Full Text] [Related]
11. Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio-oedema.
Pressler A; Grosber M; Halle M; Ring J; Brockow K
Clin Exp Dermatol; 2013 Mar; 38(2):151-3. PubMed ID: 22731986
[TBL] [Abstract][Full Text] [Related]
12. [Argentine guidelines for urticaria and angioedema].
Máspero J; Cabrera H; Ardusso L; De Gennaro M; Fernández Bussy R; Galimany J; Galimberti D; Label M; La Forgia M; Medina I; Neffen H; Troielli P; ;
Medicina (B Aires); 2014; 74 Suppl 1():1-53. PubMed ID: 25202880
[TBL] [Abstract][Full Text] [Related]
13. Chronic Urticaria: An Overview of Treatment and Recent Patents.
Hon KL; Leung AKC; Ng WGG; Loo SK
Recent Pat Inflamm Allergy Drug Discov; 2019; 13(1):27-37. PubMed ID: 30924425
[TBL] [Abstract][Full Text] [Related]
14. Therapy of chronic urticaria: a simple, modern approach.
Kaplan AP
Ann Allergy Asthma Immunol; 2014 May; 112(5):419-25. PubMed ID: 24656924
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severely recalcitrant chronic spontaneous urticaria: a discussion of relevant issues.
Wieder S; Maurer M; Lebwohl M
Am J Clin Dermatol; 2015 Feb; 16(1):19-26. PubMed ID: 25452254
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
Kaplan A; Ledford D; Ashby M; Canvin J; Zazzali JL; Conner E; Veith J; Kamath N; Staubach P; Jakob T; Stirling RG; Kuna P; Berger W; Maurer M; Rosén K
J Allergy Clin Immunol; 2013 Jul; 132(1):101-9. PubMed ID: 23810097
[TBL] [Abstract][Full Text] [Related]
17. Antihistamines in the treatment of chronic urticaria.
Jáuregui I; Ferrer M; Montoro J; Dávila I; Bartra J; del Cuvillo A; Mullol J; Sastre J; Valero A
J Investig Allergol Clin Immunol; 2007; 17 Suppl 2():41-52. PubMed ID: 18228682
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
Metz M; Ohanyan T; Church MK; Maurer M
J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
[TBL] [Abstract][Full Text] [Related]
19. [Omalizumab for therapy-resistant chronic urticaria with angioedema].
Korkmaz H; Eigelshoven S; Homey B
Hautarzt; 2010 Oct; 61(10):828-31. PubMed ID: 20842328
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab therapy for chronic spontaneous urticaria: the Israeli experience.
Rottem M; Segal R; Kivity S; Shamshines L; Graif Y; Shalit M; Kessel A; Panasoff J; Cohen S; Toubi E; Agmon-Levin N
Isr Med Assoc J; 2014 Aug; 16(8):487-90. PubMed ID: 25269339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
